✦ LIBER ✦
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
✍ Scribed by K. G. Parhofer; K. I. Birkeland; R. DeFronzo; S. Del Prato; A. Bhaumik; A. Ptaszynska
- Book ID
- 111309184
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 155 KB
- Volume
- 64
- Category
- Article
- ISSN
- 1368-5031
No coin nor oath required. For personal study only.